Phoenix Local Business
Wednesday, June 8, 2016
New Trial 'Justifies' FDA Nod for Ibrance
(MedPage Today) -- Phase III study had almost identical results as pivotal trial
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment